Key result
Office white-coat effect tail was not associated with long-term risk of cardiovascular mortality or all-cause death in men over a 60-year follow-up.
Why the study?
It was unknown whether the office white-coat effect tail predicts major long-term fatal events.
Does the office white-coat effect tail (OWCET) predict long-term cardiovascular and all-cause mortality in men?
Cohort (n=4,937)
Yes
Does the office white-coat effect tail (OWCET) predict long-term cardiovascular and all-cause mortality in men?
The office white-coat effect tail (a decrease in SBP ≥10 mmHg across multiple office measures) does not predict long-term cardiovascular or all-cause mortality in men.
Answers are grounded in this paper and cite their sources.
Does not support OWCET for long-term mortality risk stratification in men; leaves open its value in women or contemporary protocols.
Aim The aim of this study was to determine whether the office white-coat effect tail (OWCET), defined as decreasing of SBP ≥10 mmHg in multiple office systolic blood pressure measures, predicts major long-term fatal events in the nearly extinct European cohorts of the Seven Country Study (ECSCS).Material and Methods In the present analysis, 4,937 men (49 ± 5 years) were included. All-cause mortality and specific mortalities [cardiovascular mortality (CVD) including stroke, coronary heart disease (CHD) death as well as heart disease of uncertain aetiology (HDUE)] were considered using Cox models. Also non-CVD deaths were studied by Fine-Gray competing risk analysis.Results At inclusion, subjects with OWCET were significantly more hypertensive. After 60-year follow-up, OWCET was not associated with risk of both CVD [aHR: 0.95 (95% CI: 0.82–1.03), p = 0.5] and all-cause death [aHR: 0.92 (95% CI: 0.82–1.03), p = 0.16] independently of traditional risk factors (age, SBP, BMI, total cholesterol and cigarettes) in ECSCS. Same results were found for Northern and Southern Europe cohorts of ECSCS concerning CVD death [aHR: 0.98 (95% CI: 0.76–1.26), p = 0.85 and aHR: 0.95 (95% CI: 0.74–1.20), p = 0.66] and all-cause death, respectively [aHR: 0.90 (95% CI: 0.75–1.07), p = 0.23 and aHR: 0.93 (95% CI: 0.79–1.09), p = 0.38].Conclusions In a general population of men, OWCET is not associated to CVD or non-CVD and all-cause mortality and consequently cannot improve stratification of long-term CVD risks in ECSCS.
No takes yet. Share an insight, caveat, or question.
Humbert et al. (2025) conducted a cohort in General population (n=4,937). Office white-coat effect tail (OWCET) vs. No OWCET was evaluated on Cardiovascular mortality (aHR 0.95, 95% CI 0.82-1.03, p=0.5). Office white-coat effect tail was not associated with long-term risk of cardiovascular mortality or all-cause death in men over a 60-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: